首页> 外文期刊>Journal of Experimental Pharmacology >Angiotensin (1-7)/Mas receptor axis activation ameliorates the changes in fatty acid composition in diabetic rats with nephropathy
【24h】

Angiotensin (1-7)/Mas receptor axis activation ameliorates the changes in fatty acid composition in diabetic rats with nephropathy

机译:血管紧张素(1-7)/ Mas受体轴的激活改善了糖尿病肾病大鼠的脂肪酸组成的变化

获取原文
       

摘要

Abstract: Diabetes mellitus is often associated with altered fatty acids composition. This study was designed to investigate the role of angiotensin (Ang) (1-7)/Mas receptor in improving fatty acids composition in streptozotocin (STZ)-induced diabetic nephropathy (DN) in rats. Rats treated with STZ (50 mg/kg, i.p. once) developed DN after 8 weeks. Fatty acid composition was estimated in renal cortical tissue by gas chromatography. Treatment with Ang (1-7), A-779, and Ang (1-7) plus A-779 was given from week 4 to week 8. Diabetic rats exhibited a significant increase in levels of saturated fatty acids and a significant decrease in levels of polyunsaturated fatty acids (PUFAs). Treatment with Ang (1-7) significantly attenuated these diabetes-induced changes. In diabetic rats, prior administration of A-779 significantly attenuated the increase in PUFAs produced by Ang (1-7); however, for saturated fatty acids, A-779 significantly blocked the decrease in palmitic acid only. Our study, for the first time, documented that endogenous Ang (1-7) modulates fatty acid composition in rats. Further, treatment with Ang (1-7) significantly attenuated diabetes-induced changes in fatty acids composition. This may be an additional mechanism implying the renoprotective role of Ang (1-7) in diabetic rats.
机译:摘要:糖尿病通常与脂肪酸组成改变有关。这项研究旨在调查血管紧张素(Ang)(1-7)/ Mas受体在改善链脲佐菌素(STZ)诱导的糖尿病性肾病(DN)大鼠脂肪酸组成中的作用。用STZ(50 mg / kg,腹腔一次)治疗的大鼠在8周后出现DN。通过气相色谱法估计肾皮质组织中的脂肪酸组成。从第4周到第8周使用Ang(1-7),A-779和Ang(1-7)加A-779进行治疗。糖尿病大鼠的饱和脂肪酸水平显着增加,而饱和脂肪酸水平显着下降。多不饱和脂肪酸(PUFA)的水平。 Ang(1-7)治疗可显着减轻这些糖尿病引起的变化。在糖尿病大鼠中,预先给予A-779可以显着减轻Ang产生的PUFA的增加(1-7);但是,但是,对于饱和脂肪酸,A-779仅能明显阻止棕榈酸的减少。我们的研究首次证明内源性Ang(1-7)调节大鼠的脂肪酸组成。此外,用Ang(1-7)治疗可显着减轻糖尿病引起的脂肪酸组成变化。这可能是暗示Ang(1-7)在糖尿病大鼠中具有肾脏保护作用的另一种机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号